Investigating Participation Patterns of Patients in Atopic Dermatitis Clinical Trials

Starting soon

Conditions studied: Atopic Dermatitis

In brief

Clinical trials, specifically focused on atopic dermatitis, are crucial in assessing the safety and efficacy of new treatments. These trials serve as fundamental instruments in determining whether emerging medications outperform standard therapies, providing compelling evidence to support wider implementation. The main goal is to thoroughly scrutinize trial completion rates and voluntary withdrawals among this particular group of patients.

Key facts

Study ID

NCT06174493

Run by

Power Life Sciences Inc.

People needed

500

Starts

2025-01-01

Expected to finish

2027-01-01

Last updated by the study team

2024-02-12

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Ability to understand and the willingness to sign a written informed consent document
• Participant must be 18 years of age or older
• Confirmed diagnosis of atopic dermatitis

You may not qualify if…

• Enrolled in another research study
• Is pregnant, breastfeeding or expecting to conceive within the projected duration of the study
• Inability to provide written informed consent

Where it is running

• Power Life Sciences — San Francisco, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.